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Abstract
Background Transanal irrigation(TAI) has been reported to be an inexpensive and effective treatment for low anterior resec-
tion syndrome(LARS). The aim of the present prospective study was to evaluate the use of TAI in patients with significant 
LARS symptoms at a single medical center.
Methods Patients who had low anterior resection for rectal cancer between April 2015 and May 2016 at the Careggi Uni-
versity Hospital were assessed for LARS using the LARS and the Memorial Sloan-Kettering Cancer Center Bowel Function 
Instrument (MSKCC BFI) questionnaires 30–40 days after  surgery or ileostomy closure (if this was done). Quality of life 
was evaluated using a visual analog scale and the Short Form-36 Health Survey. All patients with LARS score of 30 or higher 
were included (early LARS) as were all patients with a LARS score of 30 or higher referred 6 months or longer after surgery 
performed elsewhere (chronic LARS) in the same study period. Study participants were trained to perform TAI using the 
Peristeen™ System for 6 months, followed by 3 months of enema therapy following a similar protocol.
Results Thirty-three patients were enrolled in the study. Six patients stopped the treatment. The 27 patients (19 early LARS 
and 8 chronic LARS) who completed the study had a significant decrease in the number of median daily bowel move-
ments [baseline 7 (range 0–14); 6 months 1 (range 0–4); 9 months 4 (range 0–13)]. The median LARS Score fell from 
35.1 (range 30–42) (baseline) to 12.2 (range 0–21) after 6 months (p < 0.0001) and then rose to 27 (range 5–39) after 3 
months of enema therapy. There was no difference in LARS score decrease at 6 months between the patients with early and 
chronic LARS (22.5 and 23.9 respectively; p=0.7) and there were no predictors of score decrease. Four components of the 
SF-36 significantly improved during the TAI period. The MSKCC BFI score significantly improved in several domains. 
Twenty-three patients (85%) asked to continue the treatment with TAI after the study ended.
Conclusions TAI appears to be an effective treatment for LARS and results in a marked improvement of continence and 
quality of life.  Patients may be assessed and treated for LARS early after surgery since the treatment benefit is similar to 
that observed in patients with LARS diagnosed  6 months or longer after surgery. The potential rehabilitative role of TAI 
for LARS is promising and should be further investigated.
Keywords Rectal cancer · Anterior resection · Low anterior resection syndrome · Anterior resection syndrome · Functional 
disorders · Transanal irrigation
Introduction
Many surviving rectal cancer patients experience major 
problems with bowel function after sphincter-preserving 
resection. The quality of life of rectal cancer survivors is 
closely associated with the severity of their symptoms of 
bowel dysfunction.
After low anterior resection of the rectum (and other 
rectosigmoid resection procedures), up to 80% of patients 
report symptoms that include fecal urgency, frequent bowel 
movements, stool fragmentation, emptying difficulties and 
 * J. Martellucci 
 jamjac64@hotmail.com
1 General Emergency and Minimally Invasive Surgery, 
Careggi University Hospital, largo Brambilla 3, 
50134 Florence, Italy
2 Clinical Trial Center, Careggi University Hospital, Florence, 
Italy
3 General and Endocrine Surgery, Careggi University Hospital, 
Florence, Italy
4 Oncologic and Robotic Surgery, Careggi University Hospital, 
Florence, Italy
520 Techniques in Coloproctology (2018) 22:519–527
1 3
incontinence, and increased gas [1]. Collectively these 
symptoms are referred to as low anterior resection syndrome 
(LARS). Even though many of these functional impairments 
have clinically resolved by 6–12 months after surgery, long-
term studies have reported the presence of relevant adverse 
symptoms up to 15 years after resection in about 50% of 
patients [2, 3].
Moreover, no specific treatments for LARS have been 
widely adopted. Management is empirical and symptom 
based, using existing therapies for fecal incontinence, fecal 
urgency and rectal evacuatory disorders.
Transanal irrigation (TAI) has been reported to be a cheap 
and effective treatment for LARS [4, 5].
The aim of the present study was to assess the role of 
TAI in the treatment of symptoms in patients with LARS, in 
relation to both impact on quality of life (QoL) and potential 
rehabilitative effect on colon function.
Materials and methods
From April 2015 to May 2016, all patients undergoing low 
anterior resection for rectal cancer at the Careggi Univer-
sity Hospital in Florence, Italy, were prospectively evaluated 
according to the prevention and treatment algorithm previ-
ously described [6]. All patients who underwent low anterior 
resection for rectal cancer were enrolled in an oncological 
follow-up protocol.
Between 30 and 40 days after rectal surgery (if no stoma) 
or stoma closure, the functional status and quality of life of 
all patients were evaluated. Bowel function was assessed 
using the Memorial Sloan-Kettering Cancer Center Bowel 
Function Instrument (MSKCC BFI) and the Low Anterior 
Resection Syndrome Score (LARS score).
The MSKCC BFI is the first validated questionnaire 
designed specifically for evaluating bowel function after 
sphincter-preserving surgery for rectal cancer [7, 8]. It 
consists of 18 questions about the frequency of a variety of 
LARS issues. For each question, the five frequency options 
range from “never” to “always” (except for one question 
asking about the number of bowel movements per 24 h). 
Responses can be summarized into three subscales [fre-
quency, six items (Q1, Q5, Q8–Q11); diet, four items (Q2, 
Q3, Q13, Q14); and urgency/soiling, four items (Q15–Q18)] 
by adding the scores of the items in each subscale. Addition-
ally, four single items that do not belong to a subscale relate 
to incomplete evacuation (Q4), clustering (having another 
bowel movement within 15 min of the last movement—Q6), 
knowing the difference between needing to pass gas and a 
bowel movement (Q7), and incontinence for flatus (Q12). 
A global score can be calculated as the sum of the subscale 
scores, and a total score can be calculated by adding all the 
item scores (subscale plus single item scores). A higher 
score is indicative of better bowel function.
The LARS score is a validated questionnaire that assesses 
five issues: incontinence for flatus, incontinence for liquid 
stools, frequency, clustering (the number of times the patient 
has a bowel movement within 1 h from the last bowel move-
ment) and urgency [9]. Each question has three possible 
answers and each answer has a different point value. The 
total scores are used to place patients in one of three cat-
egories: no LARS (0–20), minor LARS (21–29) and major 
LARS (30–42).
QoL was evaluated using the Short Form-36 Health Sur-
vey [10].
During the study period, a number of patients were 
referred to the hospital for long-term functional problems 
after low anterior resection. All these patients had failed 
conservative measures including lifestyle and dietary coun-
seling, optimal use of loperamide and anal plugs, and post-
operative training in pelvic floor muscle exercises.
To all the short-term and long-term patients with a LARS 
score of 30 or higher (those in the major LARS category), a 
TAI treatment was proposed, and they were enrolled in this 
prospective study after detailed informed consent.
In every patient, the integrity of the anastomosis was 
documented by endoscopy or barium enema.
Additionally, every patient who enrolled in the study was 
asked to rate the severity of each of their symptoms, using a 
visual analog scale (VAS scale) from 1 to 10, with 10 = very 
negative impact on everyday life.
For every patient, the following data were recorded and 
analyzed: clinical (age, sex, body mass index (BMI), comor-
bidities), tumor related (distance from the anal verge, stage), 
surgical (open or laparoscopy, complications), stoma (pres-
ence, type, time before closure, complications) and short-
term results (morbidity and mortality 30 days after surgery) 
were recorded and analyzed.
Tumors were considered to be in the low rectum if they 
started from < 5 cm above the pectineal line, in the mid 
rectum if between 5 and 10–12 cm (peritoneal reflection), 
and in the high rectum if > 10–12 cm (above the peritoneal 
reflection). The distance of the tumor from the anal verge 
was measured in all cases using a rigid rectoscope. The can-
cer stage was defined according to the American Joint Com-
mission on Cancer (AJCC) Tumor Node Metastasis (TNM) 
classification system.
TAI was performed using the Peristeen system (Colo-
plast, Humblebaek, Denmark). The system components 
include a bag that is filled with up to 1500 ml of lukewarm 
tap water, a coated rectal catheter with a retaining balloon 
that is inserted into the neorectum, a control unit for the reg-
ulation of air and water, and a pump for inflating the balloon 
and irrigating the rectum. All patients were instructed by a 
specially trained stoma/rehabilitative nurse, who explained 
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and assisted in the use of the device until they could inde-
pendently perform the irrigation without difficulty at home.
For the present study, the TAI protocol consisted of irri-
gation on alternate days (three or four times per week) over 
the course of 6 months. At the end of this period, the scores 
were repeated (LARS, MSKCC, SF-36). For all patients, 
the TAI therapy was then replaced with a 266 ml enema 
(2 Clisma fleet; Recordati Spa, Milan, Italy) administered 
according to the same schedule (3–4 times per week on alter-
nate days) for 3 months. Scoring was repeated at the end of 
the 3 months of enema self administration.
Statistical analysis
Data were prospectively recorded in a dedicated database; 
statistical analysis was performed using the Statistical Pack-
age for the Social Sciences (SPSS 17, Chicago, IL,USA). 
Quantitative data were given as median (range). Compari-
sons of proportions were performed using the chi-square 
test for heterogeneity. The difference between pre- and post-
treatment data was analyzed by a Wilcoxon signed rank test. 
Comparisons between the average LARS scores observed in 
different strata were analyzed according to the Mann–Whit-
ney U test. A difference was considered statistically signifi-
cant for p values < 0.05.
Results
During the study period, a total of 41 patients were evalu-
ated at 30–40 days after primary surgery (if no diversion) 
or the same interval after stoma closure. LARS symptoms 
were reported in 32 patients (78%), and 23 of them (56%) 
had scores that placed them in the major LARS category. 
Moreover, during the study period 10 additional patients 
with major LARS after previous rectal cancer resection 
were recruited after outpatient evaluation. For those 10 
patients, the median duration of functional impairment was 
21 months (range 6–102 months).
TAI treatment protocol was proposed to 33 patients (Fig 
1). There were no statistically significant differences 
between the early post-surgical and long-term patients with 
LARS regarding sex, age, indications for TAI, functional 
alterations or median LARS score (Table 1).
Median baseline self-reported functional impairment 
scores for every symptom are shown in Fig. 2.
One patient refused to participate. Five others initially 
enrolled but subsequently stopped TAI. Of those five, three 
had cancer recurrence that contraindicated continuing the 
procedure, one suspended the treatment due to proctitis and 
one suspended the treatment citing general dissatisfaction 
with the protocol.
Ultimately, 27 patients completed the study. Their median 
age was 61 years (range 29–83 years) and 17 were male 
(63%) (Table 1). Twenty-one patients had a protective colos-
tomy. The median time between low anterior resection and 
closure of the stoma was 5 months (range 1–13 months). 
Twenty-five patients had surgery for rectal cancer (1 had a 





















Impact of symptoms according to a VAS 
score (median)
Fig. 2  Baseline median self-reported functional impairment score for 
every symptom; VAS visual analog scale
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benign adenoma), 1 for ulcerative colitis and 1 for diverticu-
lar disease. Eighteen patients received neoadjuvant therapy. 
In 24 patients, an end to end stapled anastomosis (colorectal 
or coloanal) was performed. In three patients the anastomo-
sis was hand-sewn.
The median volume of water used for the irrigation was 
450 ml (range 300–1000 ml).
The median number of daily bowel movements decreased 
significantly over time [at baseline 7 (range 0–14); at 6 
months 1 (range 0–4); at 9 months 4 (range 0–13)].
The median LARS score fell from 35.1 (range 30–42) 
at baseline to 12.2 (range 0–21) at 6 months (p < 0.0001) 
(Table 2) and then rose again to 27 (range 5–39) at 9 months 
(p < 0.0001) despite the enema protocol.
Four components of the SF-36 assessment significantly 
improved (mental health, social functioning, emotional role 
functioning and bodily pain). No significant differences were 
reported in vitality, physical functioning, general health per-
ceptions and physical role functioning (Fig. 3). QoL scores 
significantly decreased after the suspension of treatment.
The MSKCC results are shown in Fig. 4. In particular, 
a significant improvement in frequency items (Q5,8,9,10), 
urgency items (Q15,17,18), incomplete emptying (Q4) and 
clustering (Q6) was reported, and a non-significant improve-
ment in dietary items, discrimination between gas and stool, 
and incontinence for flatus.
Twenty-three patients (85%) asked to resume the treat-
ment with TAI before the end of 3 months of suspension, 
due to rapid recurrence of symptoms despite enema use. 
Neither age, sex, BMI, nor any tumor- or stoma-related 
features appeared to have any statistically significant 
influence on the effect of TAI (Table 3) and recurrence 
of symptoms. Moreover, no differences in outcome were 
found between patients that started TAI postoperatively 
Table 1  Patient data









 Male 17 (63%) 13 (68%) 4 (50%) 0.4
 Female 10 (37%) 6 (32%) 4 (50%)
Age (years) 61 (range 29–83) 60 (range 29–83) 64 (range 42–79)
Procedure
 TME 21 (78%) 16 (84%) 5 (63%) 0.2
 PME 3 (11%) 2 (10%) 1 (12%)
 Sigmoid resection 2 (7%) 0 2 (25%)
 Total colectomy 1 (4%) 1 (6%) 0
Neoadjuvant therapy
 Yes 18 (66%) 13 (68%) 5 (63%) 1
 No 9 (33%) 6 (32%) 3 (37%)
T stage
 T1 1 (4%) 0 1 (12%)
 T2 11 (40%) 9 (49%) 2 (25%)
 T3 10 (37%) 6 (31%) 4 (50%)
 T4 2 (7%) 2 (10%) 0
 T0 3 (11%) 2 (10%) 1 (12%)
Table 2  Results of the LARS 
score at baseline and with 
the use of transanal irrigation 
evaluated for every item
TAI transanal irrigation
*Wilcoxon
Range Baseline Using TAI p*
Flatus control 0–7 5.1 2.5 0.005
Leakage of liquid stool 0–3 2.3 1 0.002
Bowel movements 0–5 3.7 0.9 < 0.001
New bowel movement within 1 h 0–11 9.8 1.7 < 0.001
Urgency 0–16 14.2 6.1 0.001
Total 0–42 35.1 (30–42) 12.2 (0–21) < 0.001
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(early LARS)  or after  some months, when the LARS 
symptoms were well established  (chronic  LARS). No 
significant differences were found between patients 
that continued or suspended TAI after the study period, 
considering sex, age, surgical procedure, previous radio-
therapy, previous stoma or time between surgery and TAI.
Discussion
Although dietary regimens, fiber, constipating agents and 
enemas may be considered a first-line conservative therapy 
for controlling LARS symptoms, their impact on patient sat-
isfaction and QoL is doubtful and not supported by evidence. 
Conversely, transanal irrigation (TAI) has been reported to 
be a cheap and effective treatment for incontinence and fre-
quent defecation associated with LARS [4, 5, 11, 12].
The effectiveness of TAI was previously reported for the 
treatment of symptoms induced by neurogenic bowel dys-
function [13, 14] or after dynamic graciloplasty [15] and the 
positive effects on transit time and continence were exploited 
in the management of patients with colostomy [16].
The effect of the irrigation is in part due to a simple 
mechanical wash-out effect, but studies of enema adminis-
tration through colostomies have shown that irrigation with 
an enema > 250 ml generates colonic mass movements and 
other colonic functional responses [17, 18], suggesting that 
a regular management of bowel function through irrigation 
























Fig. 4  The Memorial Sloan-Kettering Cancer Center Bowel Function 
Instrument score before and at the end of TAI (adapted: higher scores 
means better function for all the items); TAI transanal irrigation
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could have a rehabilitative effect on colonic motility. For 
the present study, the importance of performing TAI always 
at the same hour of the day, with the same time interval 
between tqo irrigations, without skipping any and maintain-
ing a definite rhythm was explained to all the patients. After 
the 6 months of treatment with TAI, similar principles were 
followed during the enema regime, but the results of the 
present study failed to confirm a possible rehabilitative role 
of enema. The positive effect was usually maintained only 
during the TAI treatment phase.
Factors reported to correlate with a positive outcome for 
TAI include neurogenic bowel dysfunction and anal insuf-
ficiency as the underlying pathology, low rectal volume, 
low maximal rectal capacity and low anal squeeze pressure 
increment, factors that could be easily detected in patients 
with LARS [12].
Impaired bowel function and incontinence in LARS 
patients are usually related to a combination of colonic dys-
motility, neorectal reservoir dysfunction and anal sphincter 
dysfunction. While neorectal reservoir function could ben-
efit from anastomotic technique [19] or volumetric rehabili-
tation to enhance neorectal compliance and capacity, and 
sphincteric dysfunction could benefit from multimodal pel-
vic floor rehabilitation [20, 21], sacral neuromodulation [22, 
23] or posterior tibial nerve stimulation [24], the problem of 
colonic dysmotility still remains unsolved. It may be the case 
that removal of the rectum and/or the rectosigmoid junc-
tion eliminates the physiological distal control center for 
regulation of bowel transit, removing the negative feedback 
signals and leaving the bowel activity without a brake. In 
recent years, periodic (for the most part retrograde) motor 
phenomena have been documented in the rectum (“rectal 
motor complex”, RMC) [25] and in the more distal colonic 
segments (“periodic colonic motor activity”) [26]. The 
physiological significance of these phenomena is still under 
investigation, although for the RMC a continence-preserving 
mechanism (especially when sleeping) and negative feed-
back to transit and gastro/entero-colic reflexes have been 
hypothesized [27].
TAI may be the only treatment option that directly affects 
bowel dysmotility, mimicking the rectal pacemaker control 
and potentially giving a rhythm to bowel transit. Moreover, it 
has been shown that long-term TAI can increase urge rectal 
volume at manometric recording, suggesting a potential role 
of TAI in treating urgency [28].
In the present study, symptoms such as clustering or 
frequent bowel movements, strongly related to colonic 
dysmotility, were reported as highly disabling, together 
with urgency. Specialists tend to overestimate the impact 
of incontinence for liquid stool and frequent bowel move-
ments, while underestimating the impact of urgency and 
clustering [29]. In fact, in previous studies about TAI in 
patients affected by LARS, only scores related to fecal 
incontinence were used for patient selection and evalua-
tion of outcomes. This could create a significant bias. To 
the best of our knowledge, the present study is the first in 
Table 3  Response to transanal 
irrigation in sub-group analysis










 Male 17 35.8 (32–42) 12.0 (4–16) 23.8 0.3
 Female 10 33.9 (30–41) 12.7 (0–21) 21.2
Age, years, (median)
 < 70 16 35.2 (30–41) 12.0 (0–18) 23.2 0.6
 > 70 11 35.0 (32–42) 12.6 (4–21) 22.4
Procedure
 TME 21 34.4 (30–40) 12.2 (4–21) 22.2 0.3
 =thers 6 37.5 (33–42) 12.1 (0–18) 25.4
Neoadjuvant
 Yes 18 34.7 (30–42) 12 (4–20) 22.7 0.8
 No 9 35.8 (32–42) 12.7 (0–21) 23.1
Stoma
 Yes 21 35.4 (30–42) 12.1 (4–20) 23.3 0.3
 No 6 34.1 (30–38) 12.6 (0–21) 21.5
Time between surgery and TAI
 < 6 months 19 34.6 (30–42) 12.1 (4–20) 22.5 0.7
 > 6 months 8 36.5 (31–42) 12.6 (0–21) 23.9
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which patients were evaluated with dedicated validated 
scores for LARS. The MSKCC BFI and LARS scores are 
considered to be the best for assessing anorectal function 
after rectal cancer surgery [30]. For comprehensive and 
in-depth evaluation of LARS, the MSKCC BFI would be 
the questionnaire of choice. However, the MSKCC BFI’s 
length (18 questions) and scoring method (which involves 
recoding, three subscale scores, a global score, and a total 
score) may limit its practicality. For rapid screening, the 
LARS score is preferable. Both instruments are valid, reli-
able, and able to detect clinically relevant differences.
The potential of TAI for treating LARS merits further 
investigation, although a cautious approach will be nec-
essary to avoid the possibility of perforation in this at-
risk group. In a collection of incidents caused by medi-
cal devices recorded by the European Community, the 
United States Food and Drug Association (FDA) and other 
national competent authorities, six perforations related to 
TAI were registered, and reported in a global audit on 
TAI-related bowel perforations[31].
This problem may be linked to the fact that the neorec-
tum and the surroundings of the anastomosis have abnor-
mal biomechanical properties that make the bowel wall 
more fragile. The same is probably true for other types of 
rectal surgery such as the stapled transanal rectal resection 
or ventral mesh rectopexy for obstructed defecation [32], 
and any kind of surgery for rectal prolapse.
While it is possible that the perforation rate observed 
in this cohort could be due to selection bias, the apparent 
increased risk in patients with prior rectal surgery empha-
sizes that pretreatment endoscopic evaluation of the rec-
tum and of the integrity of the anastomosis are mandatory 
in such patients [33]. Furthermore, patients should be 
informed of the increased risk.
However, the weighted average risk of a bowel perfora-
tion was 6 per million (1:167.000) irrigation procedures 
[31]. In comparison, the standard quoted risk of perfora-
tion is 20 per million irrigation procedures (all irrigation 
systems) [12], 1:40.000 during flexible sigmoidoscopy 
[34], 1:1.000 during colonoscopy [35] and 1:10.000 during 
barium enema procedures [36]. In the present study, QoL 
and the LARS scores improved significantly. The majority 
of patients were able to empty their bowels with one to two 
bowel movements in 24–48 h, and they avoided the prob-
lem of night evacuation, which is probably a significant 
factor in improving QoL.
Unlike neurogenic patients, for whom the use of TAI 
represents a complex and often not autonomous maneu-
ver with a high drop-out rate [37], a very low number of 
patients in the present study discontinued treatment. This 
is probably related to the simplicity of the procedure in 
self-sufficient trained and motivated patients, for whom 
TAI means a definite symptom-free period and a signifi-
cant improvement of QoL.
A potential limitation of the present study could be the 
presence of patients with chronic LARS [median duration 
of functional impairment: 21 months (range 6–102 months)] 
as well as patients with early symptoms after rectal surgery. 
Some patients may notice that their symptoms resolve over 
time while others may continue to have symptoms and it is 
assumed that most patients clinically recover from functional 
impairments by 6–12 months after the operation. However, 
the only mechanisms that probably could be affected by time 
are neorectal reservoir dysfunction, (neorectal compliance 
and capacity could be recovered over time), and sphincteric 
muscular dysfunction (which can be partially recovered 
with training). Unfortunately, colonic dysfunction and nerve 
damage (due to surgery or adjuvant treatments) are strongly 
related to the main symptoms, and do not seem much influ-
enced by time, often becoming permanent. In fact, long-
term studies have reported the presence of relevant adverse 
symptoms up to 15 years after resection in about 50% of 
patients [2, 3]. No statistically significant differences were 
noted between the two groups in the present study.
However, the authors believe that early treatment of 
functional impairment after rectal surgery has the potential 
to enhance recovery and reduce the incidence of perma-
nent dysfunctions [6].
Conclusions
The results of the present study confirm that TAI is an effec-
tive treatment of LARS and results in a marked improvement 
of continence scores and QOL. The rehabilitative role of 
TAI in the treatment of LARS still needs to be clarified and 
further studies are required to identify the best approach to 
correcting functional dysfunctions after rectal surgery.
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